Key result
Long noncoding RNAs exhibit aberrant expression linked to anesthetic-induced developmental neurotoxicity and perioperative neurocognitive disorders, highlighting their potential as therapeutic targets.
Why the study?
The mechanisms by which early-life anesthetic exposure affects brain function remain poorly understood, limiting the efficacy of diagnostic and therapeutic options in human studies.
This review highlights the potential of long noncoding RNAs as diagnostic and therapeutic targets for preventing perioperative neurocognitive disorders and anesthetic-induced developmental neurotoxicity.
Answers are grounded in this paper and cite their sources.
Should not yet change anesthetic practice; hypothesis-generating for lncRNA targets in perioperative neuroprotection.
Preclinical investigations in animal models have consistently demonstrated neurobiological changes and life-long cognitive deficits following exposure to widely used anesthetics early in life. However, the mechanisms by which these exposures affect brain function remain poorly understood, therefore, limiting the efficacy of current diagnostic and therapeutic options in human studies. The human brain exhibits an abundant expression of long noncoding RNAs (lncRNAs). These biologically active transcripts play critical roles in a diverse array of functions, including epigenetic regulation. Changes in lncRNA expression have been linked with brain development, normal CNS processes, brain injuries, and the development of neurodegenerative diseases, and many lncRNAs are known to have brain-specific expression. Aberrant lncRNA expression has also been implicated in areas of growing importance in anesthesia-related research, including anesthetic-induced developmental neurotoxicity (AIDN), a condition defined by neurological changes occurring in patients repeatedly exposed to anesthesia, and the related condition of perioperative neurocognitive disorder (PND). In this review, we detail recent advances in PND and AIDN research and summarize the evidence supporting roles for lncRNAs in the brain under both normal and pathologic conditions. We also discuss lncRNAs that have been linked with PND and AIDN, and conclude with a discussion of the clinical potential for lncRNAs to serve as diagnostic and therapeutic targets for the prevention of these neurocognitive disorders and the challenges facing the identification and characterization of associated lncRNAs.
No takes yet. Share an insight, caveat, or question.
Pant et al. (2020) conducted a review in Perioperative neurocognitive disorders and anesthetic-induced developmental neurotoxicity. Long noncoding RNAs (lncRNAs) was evaluated. Long noncoding RNAs exhibit aberrant expression linked to anesthetic-induced developmental neurotoxicity and perioperative neurocognitive disorders, highlighting their potential as therapeutic targets.
Synapse has enriched 10 related papers. Consider them for comparative context: